Velarion · Company Intelligence
Compensation Brief
Fiscal year 2025 · Filings through 2026-09-14

Fortrea Holdings (FTRE)

CEO Anshul Thakral was paid $11,584,483 in fiscal year 2025, the 67th percentile of its disclosed peer group (SEC filing 0001193125-26-178733 ↗): executive and director compensation, incentive-plan design, equity activity, and governance — every figure in this brief is traceable to its exact location in the company’s SEC filing — the document, the section, the page, and the table, linked directly.

$11,584,483
Anshul Thakral total, FY2025
67th
CEO pay percentile vs peers
196:1
CEO-to-median pay ratio
94.82%
Say-on-pay support, latest vote

Track this company's pay every filing: join the Pro seat waitlist

Velarion Pro: every company page, peer tools and exports, one seat — $1,200/year

A confirmation now and one email when Pro opens, and nothing else. Privacy

FTRE's next annual pay disclosure, estimated April 26, 2027.est. Filing ↗

01

Summary Compensation Table — fiscal year 2025

Named executive officerSalaryBonusStock awardsOption awardsNon-equity incentivePension / NQDCAll otherTotal
Anshul Thakral$401,923$0$10,479,169$0$687,500$0$15,891$11,584,483
Chief Executive Officer and Director
Thomas Pike465,385000007,326,3387,791,722
Former Chief Executive Officer
Jill McConnell506,5770862,994—295,202016,1001,680,873
Chief Financial Officer
Mark Morais506,5770804,1210295,202010,8881,616,788
Chief Operating Officer and President, Clinical Services
Peter Neupert389,4230710,00000045,8381,145,261
Chairman and Former Interim Chief Executive Officer

A dash means the company reported no figure in that column; 0 means it reported zero. Figures are as printed in the filing, without adjustment.

Three-year trend — total compensation per named executive

Named executive officerFY2025 totalFY2024 totalFY2023 totalΔ FY2024→2025
Anshul Thakral$11,584,483———
Thomas Pike7,791,7221,713,90626,320,395↑ +6,077,816
Jill McConnell1,680,8731,342,0173,078,275↑ +338,856
Mark Morais1,616,7881,336,761—↑ +280,027
Peter Neupert1,145,261———

Prior-year totals as disclosed in the corresponding proxy; deltas are computed values with the derivation shown in the register.

You have just read Fortrea Holdings's Summary Compensation Table. The whole free brief as a PDF, emailed now, with every figure cited — then a few short notes on the deeper FTRE reports.

We send the PDF right away, then up to three short notes. Reply “unsubscribe” to any of them, any time.

How we handle your data → Privacy

Companies that benchmark against FTRE
3 companies name FTRE as a compensation peer

The list of companies that name FTRE as a peer is temporarily unavailable — recheck shortly.

01b

Executives — the named officers

One page per officer: the same table above, read for one person at a time — his own figure and every fiscal year the register holds.

ExecutiveRoleFY2025 total
Anshul ThakralCEO$11,584,483
Peter NeupertExecutive$1,145,261
Mark MoraisPresident$1,616,788
Thomas PikeChief Executive Officer$7,791,722
Jill McConnellCFO$1,680,873
01c

Board of directors

One page per director: the seat, the committees and the fee table, read for one person at a time.

DirectorRoleFY2025 total
David SmithIndependent Director$317,466
Dr. Amrit RayIndependent Director$340,000
Edward PesickaIndependent Director$300,000
Erin L. RussellIndependent Director$502,500
Machelle SandersIndependent Director$310,000
R. Andrew EckertFormer director (through FY2025)$75,000
William SharbaughIndependent Director$22,500
02

Equity transactions since the proxy statement was filed

Every insider equity transaction reported on Form 4 after the 2025 proxy statement — acquisitions, dispositions, exercises, and withholdings — and therefore not reflected in any table in that document.

InsiderRoleTransaction dateCodeSharesPriceValueSecuritySource
Peter M. NeupertDirector2026-05-14D148,536$0$0Derivative, Class A CommonForm 4 ↗
Peter M. NeupertDirector2026-05-14A148,53600CommonForm 4 ↗
Robert ParksChief Accounting Officer2026-05-18D2,0001326,880CommonForm 4 ↗
Jill McConnellChief Financial Officer2026-06-01D11,00600Derivative, Class A CommonForm 4 ↗
Jill McConnellChief Financial Officer2026-06-01A11,00600CommonForm 4 ↗
Mark MoraisChief Operating Officer2026-06-01D11,00600Derivative, Class A CommonForm 4 ↗
Mark MoraisChief Operating Officer2026-06-01A11,00600CommonForm 4 ↗
Mark MoraisChief Operating Officer2026-06-02D4,8661575,374CommonForm 4 ↗
Jill McConnellChief Financial Officer2026-06-02D4,8661575,374CommonForm 4 ↗
Erin L. RussellDirector2026-06-10A12,85200Derivative, Class A CommonForm 4 ↗
Erin L. RussellDirector2026-06-10D38,81700Derivative, Class A CommonForm 4 ↗
Erin L. RussellDirector2026-06-10A38,81700CommonForm 4 ↗
William SharbaughDirector2026-06-10A12,85200Derivative, Class A CommonForm 4 ↗
Dr. Amrit RayDirector2026-06-10A12,85200Derivative, Class A CommonForm 4 ↗
Dr. Amrit RayDirector2026-06-10D38,81700Derivative, Class A CommonForm 4 ↗
Dr. Amrit RayDirector2026-06-10A38,81700CommonForm 4 ↗
Mark MoraisChief Operating Officer2026-06-10D4,6741778,617CommonForm 4 ↗
Peter M. NeupertDirector2026-06-10A12,85200Derivative, Class A CommonForm 4 ↗
Edward PesickaDirector2026-06-10A12,85200Derivative, Class A CommonForm 4 ↗
Edward PesickaDirector2026-06-10D38,81700Derivative, Class A CommonForm 4 ↗
Edward PesickaDirector2026-06-10A38,81700CommonForm 4 ↗
David SmithDirector2026-06-10A12,85200Derivative, Class A CommonForm 4 ↗
David SmithDirector2026-06-10D38,81700Derivative, Class A CommonForm 4 ↗
David SmithDirector2026-06-10D18,24416298,107CommonForm 4 ↗
David SmithDirector2026-06-10A38,81700CommonForm 4 ↗
Machelle SandersDirector2026-06-10A12,85200Derivative, Class A CommonForm 4 ↗
Machelle SandersDirector2026-06-10D38,81700Derivative, Class A CommonForm 4 ↗
Machelle SandersDirector2026-06-10A38,81700CommonForm 4 ↗
David SmithDirector2026-07-20A6,59800CommonForm 4 ↗
Machelle SandersDirector2026-08-03D9,70018174,697CommonForm 4 ↗
David SmithDirector2026-08-03A15,84000Derivative, Class A CommonForm 4 ↗
Anshul ThakralDirector2026-08-04D416,66600Derivative, Class A CommonForm 4 ↗
Anshul ThakralDirector2026-08-04A416,66600CommonForm 4 ↗
Anshul ThakralDirector2026-08-05D50,41719972,040CommonForm 4 ↗
Anshul ThakralDirector2026-08-05D49,45219941,072CommonForm 4 ↗
Anshul ThakralDirector2026-08-06D55,975181,010,909CommonForm 4 ↗
Anshul ThakralDirector2026-08-06D55,882181,015,376CommonForm 4 ↗
Mark MoraisChief Operating Officer2026-08-18D11,31300Derivative, Class A CommonForm 4 ↗
Mark MoraisChief Operating Officer2026-08-18A11,31300CommonForm 4 ↗
Mark MoraisChief Operating Officer2026-08-19D4,8921888,985CommonForm 4 ↗
Mark MoraisChief Operating Officer2026-09-08D7,15700Derivative, Class A CommonForm 4 ↗
Mark MoraisChief Operating Officer2026-09-08A7,15700CommonForm 4 ↗
Dividend-equivalent accruals2026-09-08—850——1 insider, 1 accrual row
Erin L. RussellInterim CAO2026-09-08A85000CommonForm 4 ↗
Erin L. RussellInterim CAO2026-09-09D246174,145CommonForm 4 ↗
Mark MoraisChief Operating Officer2026-09-09D3,1491753,061CommonForm 4 ↗
Jason Fredrick KnoblauchChief Financial Officer2026-09-10A144,43400Derivative, Class A CommonForm 4 ↗

Transaction codes per Form 4: A acquisition · S open-market sale · F tax withholding · M option exercise · G gift. Value = shares × price as reported. Dividend-equivalent and fractional-share accrual rows (derivative Class A, under $10,000 and under 2,000 shares) are aggregated per date; every row appears in full below.

View all 47 transactions
InsiderRoleTransaction dateCodeSharesPriceValueSecuritySource
Peter M. NeupertDirector2026-05-14D148,536$0$0Derivative, Class A CommonForm 4 ↗
Peter M. NeupertDirector2026-05-14A148,53600CommonForm 4 ↗
Robert ParksChief Accounting Officer2026-05-18D2,0001326,880CommonForm 4 ↗
Jill McConnellChief Financial Officer2026-06-01D11,00600Derivative, Class A CommonForm 4 ↗
Jill McConnellChief Financial Officer2026-06-01A11,00600CommonForm 4 ↗
Mark MoraisChief Operating Officer2026-06-01D11,00600Derivative, Class A CommonForm 4 ↗
Mark MoraisChief Operating Officer2026-06-01A11,00600CommonForm 4 ↗
Mark MoraisChief Operating Officer2026-06-02D4,8661575,374CommonForm 4 ↗
Jill McConnellChief Financial Officer2026-06-02D4,8661575,374CommonForm 4 ↗
Erin L. RussellDirector2026-06-10A12,85200Derivative, Class A CommonForm 4 ↗
Erin L. RussellDirector2026-06-10D38,81700Derivative, Class A CommonForm 4 ↗
Erin L. RussellDirector2026-06-10A38,81700CommonForm 4 ↗
William SharbaughDirector2026-06-10A12,85200Derivative, Class A CommonForm 4 ↗
Dr. Amrit RayDirector2026-06-10A12,85200Derivative, Class A CommonForm 4 ↗
Dr. Amrit RayDirector2026-06-10D38,81700Derivative, Class A CommonForm 4 ↗
Dr. Amrit RayDirector2026-06-10A38,81700CommonForm 4 ↗
Mark MoraisChief Operating Officer2026-06-10D4,6741778,617CommonForm 4 ↗
Peter M. NeupertDirector2026-06-10A12,85200Derivative, Class A CommonForm 4 ↗
Edward PesickaDirector2026-06-10A12,85200Derivative, Class A CommonForm 4 ↗
Edward PesickaDirector2026-06-10D38,81700Derivative, Class A CommonForm 4 ↗
Edward PesickaDirector2026-06-10A38,81700CommonForm 4 ↗
David SmithDirector2026-06-10A12,85200Derivative, Class A CommonForm 4 ↗
David SmithDirector2026-06-10D38,81700Derivative, Class A CommonForm 4 ↗
David SmithDirector2026-06-10D18,24416298,107CommonForm 4 ↗
David SmithDirector2026-06-10A38,81700CommonForm 4 ↗
Machelle SandersDirector2026-06-10A12,85200Derivative, Class A CommonForm 4 ↗
Machelle SandersDirector2026-06-10D38,81700Derivative, Class A CommonForm 4 ↗
Machelle SandersDirector2026-06-10A38,81700CommonForm 4 ↗
David SmithDirector2026-07-20A6,59800CommonForm 4 ↗
Machelle SandersDirector2026-08-03D9,70018174,697CommonForm 4 ↗
David SmithDirector2026-08-03A15,84000Derivative, Class A CommonForm 4 ↗
Anshul ThakralDirector2026-08-04D416,66600Derivative, Class A CommonForm 4 ↗
Anshul ThakralDirector2026-08-04A416,66600CommonForm 4 ↗
Anshul ThakralDirector2026-08-05D50,41719972,040CommonForm 4 ↗
Anshul ThakralDirector2026-08-05D49,45219941,072CommonForm 4 ↗
Anshul ThakralDirector2026-08-06D55,975181,010,909CommonForm 4 ↗
Anshul ThakralDirector2026-08-06D55,882181,015,376CommonForm 4 ↗
Mark MoraisChief Operating Officer2026-08-18D11,31300Derivative, Class A CommonForm 4 ↗
Mark MoraisChief Operating Officer2026-08-18A11,31300CommonForm 4 ↗
Mark MoraisChief Operating Officer2026-08-19D4,8921888,985CommonForm 4 ↗
Mark MoraisChief Operating Officer2026-09-08D7,15700Derivative, Class A CommonForm 4 ↗
Mark MoraisChief Operating Officer2026-09-08A7,15700CommonForm 4 ↗
Erin L. RussellInterim CAO2026-09-08D85000Derivative, Class A CommonForm 4 ↗
Erin L. RussellInterim CAO2026-09-08A85000CommonForm 4 ↗
Erin L. RussellInterim CAO2026-09-09D246174,145CommonForm 4 ↗
Mark MoraisChief Operating Officer2026-09-09D3,1491753,061CommonForm 4 ↗
Jason Fredrick KnoblauchChief Financial Officer2026-09-10A144,43400Derivative, Class A CommonForm 4 ↗
03

Grants of plan-based awards — fiscal year 2025

ExecutiveAwardGrant dateThresholdTargetGrantedMaximumGrant-date fair value
Jill McConnellPSU2025-03-201,9083,816—7,632$26,979
Mark MoraisPSU2025-03-201,9083,816—7,63226,979
Peter NeupertRSU2025-05-14——148,536—710,000
Thomas PikeRSU2025-03-20——67,731—594,000
Anshul ThakralPSU2025-08-04208,333416,667—833,3332,454,169
Jill McConnellPSU2025-03-2011,89023,780—47,561193,331
Mark MoraisPSU2025-03-2010,86521,730—43,461176,665
Anshul ThakralRSU2025-08-04——1,250,000—8,025,000
Jill McConnellRSU2025-03-06——14,313—153,006
Mark MoraisRSU2025-03-06——14,313—153,006
Jill McConnellRSU2025-03-07——45,850—489,678
Mark MoraisRSU2025-03-07——41,898—447,471
03b

Vehicle mix — grant-date fair value by award type

Named executive officerTime-vested (RSU)Performance-vested (PSU)Options / SARs% performance-vested
Jill McConnell$642,684$220,310$025.5%
Mark Morais600,477203,644025.3%
Peter Neupert710,000000.0%
Thomas Pike594,000000.0%
Anshul Thakral8,025,0002,454,169023.4%

% performance-vested = PSU grant-date fair value ÷ (RSU + PSU + Options), a computed value with the derivation shown in the register.

04

Outstanding equity awards at fiscal year-end 2025

ExecutiveAwardShares unvestedExercise priceMarket value unvested
Mark MoraisRSU11,313—$195,149
Jill McConnellRSU8,568—147,798
Jill McConnellRSU45,850—790,913
Jill McConnellRSU11,313—195,149
Mark MoraisRSU8,568—147,798
Mark MoraisRSU11,006—189,854
Jill McConnellRSU11,006—189,854
Anshul ThakralPSU833,333—14,375,000
Mark MoraisRSU2,255—38,899
Jill McConnellRSU1,685—29,066
Jill McConnellPSU15,264—263,304
Mark MoraisPSU15,264—263,304
Jill McConnellRSU7,157—123,458
Mark MoraisRSU7,157—123,458
Anshul ThakralRSU1,250,000—21,562,500
Peter NeupertRSU148,536—2,562,246
Jill McConnellPSU47,560—820,410
Mark MoraisPSU43,461—749,702
Mark MoraisRSU41,898—722,741
05

Incentive-plan design — the Compensation Discussion & Analysis

The MDCC's compensation philosophy is to appropriately recognize and reward executives for both Company and individual performance. The MDCC generally believes that it is important to place more emphasis on pay that is performance-based and at-risk, and that pay mix should be more heavily weighted toward variable compensation.

CEO STI target (% of salary)150%
CEO LTI target (% of salary)—
Independent consultantPay Governance LLC
Clawback policytrue
Anti-hedgingtrue
Anti-pledgingTrue
06

Say-on-pay — recent advisory votes

Meeting yearMeeting dateForAgainstAbstainSupportOutcome
20262026-06-0973,544,2933,877,113140,98094.82%Passed
20252025-04-1768,050,2813,302,818182,52095.13%Passed
20242024-05-1471,701,4666,512,81563,01291.67%Passed

Rows are labeled by annual-meeting year, with the meeting date beside each; the vote held in a given year acts on the prior fiscal year's compensation.

Say-on-pay — history, company's computation

Meeting yearMeeting dateApproval — company's computation
20262026-06-0994.82%a
20252025-04-1795.13%b
20242024-05-1491.67%c

a. Approved under the standard stated in the filing — “Abstentions have the same effect as votes against the ratification of the appointment of Deloitte & Touche LLP, or the Say-on-Pay Vote.”.

b. Approved under the standard stated in the filing — “Abstentions have the same effect as votes against the ratification of the appointment of Deloitte & Touche LLP, the Say-on-Pay Vote or the approval of the A&R Incentive Plan.”.

c. Approved under the standard stated in the filing — “Abstentions have the same effect as votes against the proposal.”.

Approval percentages are the company's own reported computations under its own stated standard, not recomputed by Velarion. Where a company does not state a standard, none is assumed.

07

CEO pay ratio

Ratio (CEO : median employee)196 : 1
CEO total compensation$12,282,560
Median employee compensation$62,683
08

Director compensation — fiscal year 2025

DirectorCash feesStock awardsOption awardsNon-equity incentiveAll otherTotal
Erin L. RussellIndependent · Audit · Nominating, Corporate Governance and Compliance · Newly elected$82,500$420,000$0$0$0$502,500
Dr. Amrit RayIndependent · Management Development and Compensation (Chair) · Nominating, Corporate Governance and Compliance130,000210,000000340,000
David SmithIndependent · Audit (Chair) · Management Development and Compensation107,466210,000000317,466
Machelle SandersIndependent · Management Development and Compensation · Nominating, Corporate Governance and Compliance (Chair)100,000210,000000310,000
Edward PesickaIndependent · Audit · Management Development and Compensation90,000210,000000300,000
R. Andrew EckertIndependent · Departed during FY75,000000075,000
William SharbaughIndependent · Audit · Management Development and Compensation · Nominating, Corporate Governance and Compliance · Newly elected22,500000022,500
Thomas PikeNot independent · Departed during FY000000
Anshul ThakralEmployee director · Newly elected000—00
Peter M. NeupertIndependent · Board Chair · Nominating, Corporate Governance and Compliance000000
09

Board fee structure and ownership guideline

Annual cash retainer$90,000
Annual equity retainer$210,000
Per board meeting fee—
Committee chair fees (audit / comp / nom-gov)25,000 / 20,000 / 20,000
Stock ownership guideline5x annual base salary (CEO: 6x; Other NEOs: 3x)
09b

Total cost of the board

ComponentFY2025
Cash retainers and fees$607,466
Equity awards (grant-date value)$1,260,000
All other compensation$0
Total cost of the board$1,867,466

Computed as the sum of the director compensation table rows above; inputs and formula shown in the register.

10

Disclosed peer group — fiscal year 2025

The compensation peer group as the company disclosed it in its own proxy — the reference set behind the percentile above.

10a

Peer reciprocity

Of the companies Fortrea Holdings names as compensation peers, which name it back in their own disclosed peer groups. A peer set the market reciprocates reads differently from one selected in a single direction.

Reciprocity shown where the peer's own current proxy has been read — each mark is cited in the register to that peer's filing. A dash means the peer's current proxy was read and names no reciprocal group including Fortrea Holdings.

10b

Chief executive pay against the peer group

Most recent fiscal-year chief executive compensation at each disclosed peer, taken from that company's own proxy statement.

RankCompanyFYChief executiveSalaryStock awardsOption awardsNon-equity incentiveTotal
1Exelixis, Inc.2025Michael Morrissey$1,306,040$30,539,552$0$1,382,591$33,239,183
2Bausch + Lomb Corporation2025Brenton Saunders1,600,00023,778,5782,799,9984,000,00032,194,326
3Jazz Pharmaceuticals plc2025Renee Gala1,003,26916,138,43301,980,00019,151,558
4Organon & Co.2025Kevin Ali1,088,46210,251,9893,249,999015,813,296
5Charles River Laboratories International, Inc.2025James Foster1,545,63611,601,08902,182,66615,435,220
6Haemonetics Corporation2026Christopher Simon1,100,0087,561,9871,504,9681,834,25012,044,701
7Fortrea Holdings2025Anshul Thakral401,92310,479,1690687,50011,584,483
8Medpace Holdings, Inc.2025August Troendle937,41709,999,999011,443,766
9QuidelOrtho Corporation2025Brian Blaser1,000,0008,965,82201,274,50011,255,782
10Sotera Health Company2025Michael Petras1,130,6998,022,40001,484,89010,656,063
11Integra LifeSciences2025Mojdeh Poul1,009,6165,219,8682,250,011174,5639,375,551
12Enovis Corporation2025Damien McDonald634,6157,262,6440812,7499,242,161
13Perrigo Company plc2025Patrick Lockwood-Taylor1,223,3336,990,5640687,2509,042,603
14DENTSPLY SIRONA Inc.2025Daniel Scavilla431,7533,484,4883,221,523437,1508,760,139
15Bio-Rad Laboratories2025Norman Schwartz1,089,8774,856,5741,458,975562,0887,995,841
16Alkermes plc2025Richard Pops1,250,76905,020,8121,626,0007,915,081
17CONMED Corporation2025Patrick Beyer891,1002,499,9712,499,9771,129,4697,634,873
18Teleflex Incorporated2025Liam Kelly1,144,4002,005,6042,886,518227,2806,732,419
19Bruker Corporation2025Frank Laukien976,5541,623,4071,488,109587,2704,706,388

Each peer's compensation is from its most recently filed proxy; fiscal years differ by company. Each peer's figures come from its own filings; the subject company is highlighted. Peers whose chief executive compensation is outside our coverage universe are stated as such, never left blank.

10c

Incentive design against the same peers

CompanyAnnual incentive payoutLong-term vehicle mixPSU measures include TSRCompensation consultant
Fortrea Holdings68.5%PSU 50 · RSU 50NoPay Governance LLC
Alkermes plc130%PRSU 53 · RSU 24 · Option 23Yes — Relative Total Shareholder Return (TSR)Alpine Rewards LLC
Bausch + Lomb Corporation100%PSU 60 · RSU 20 · Options 20Yes — Relative Total Shareholder Return (rTSR)Pay Governance
Bio-Rad Laboratoriesnot disclosednot disclosednot disclosedCompensia, Inc.
Bruker Corporation43.0%RSU 52 · Options 48not disclosedAon's Human Capital Solutions Practice
Charles River Laboratories International, Inc.139%PSU 60 · RSU 40Yes — Three-year rTSRPay Governance
CONMED Corporation126.8%Options 50 · PSU 50Yes — rTSRCompensia, Inc.
DENTSPLY SIRONA Inc.66%PSU 50 · Options 50NoFrederic W. Cook & Co., Inc.
Enovis Corporation92.2%PSU 50 · RSU 50Yes — Relative TSR vs. S&P 500 Health Care Equipment Select Industry IndexFW Cook
Exelixis, Inc.105%PSU 50 · RSU 50Yes — 2025 Relative TSR GoalAon
Haemonetics Corporation133.4%PSU 60 · RSU 20 · Options 20Yes — Relative Total Shareholder Return (rTSR)Pearl Meyer & Partners, LLC
Integra LifeSciences40%PSU 50 · Options 25 · RSU 25NoWTW
Jazz Pharmaceuticals plc150%PSU 50 · RSU 50Yes — Relative TSRAon
Medpace Holdings, Inc.52.5%Options 100not disclosedTotal Compensation Solutions (TCS)
Organon & Co.72%PSU 50 · RSU 25 · Options 25Yes — Three-Year Relative TSRKorn Ferry
Perrigo Company plc44.3%PSU 70 · RSU 30Yes — Relative TSR (rTSR)FW Cook
QuidelOrtho Corporation127%PSU 60 · RSU 40Yes — Total Shareholder Return (TSR)Compensia
Sotera Health Company103%PSU 40 · RSU 40 · Other 20NoExequity, LLP
Teleflex Incorporated25.9%Options 55 · RSU 25 · PSU 20Yes — Absolute TSRFW Cook

Read from each company's Compensation Discussion and Analysis: annual incentive payout as a percentage of target, the disclosed long-term vehicle mix, whether performance-share measures include a total shareholder return component, and the retained compensation consultant. “Not disclosed” appears only where the company's filing does not state the item.

10d

Frequently asked questions

Who was the highest-paid executive at Fortrea Holdings in fiscal 2025?
As disclosed, Anshul Thakral (Chief Executive Officer and Director) was the highest-paid executive at Fortrea Holdings in fiscal 2025, with total compensation of $11,584,483.
How does Fortrea Holdings's chief executive pay compare to its disclosed peer group?
As disclosed, Anshul Thakral's total compensation ranked at the 67th percentile of Fortrea Holdings's disclosed peer group.
What is Fortrea Holdings's CEO-to-median employee pay ratio?
As disclosed, Fortrea Holdings's CEO-to-median employee pay ratio was 196:1.
How did shareholders vote on Fortrea Holdings's executive compensation?
As disclosed, 94.82% of shareholders supported Fortrea Holdings's executive compensation in the latest say-on-pay vote.
How much does Fortrea Holdings spend in total on board compensation for fiscal 2025?
As disclosed, Fortrea Holdings reported total board compensation of $1,867,466 for fiscal 2025.

Answers are drawn only from the figures disclosed in this brief and cited to their location in the source filing. Where a figure required for an answer is not disclosed, that is stated rather than estimated.

11

Source register

Each figure's location is given both for the eye (section · page · table · row · column) and for a script (table/row/column index and exact character span in the filed document). Any figure can be independently confirmed against the source.

#SupportsDocumentFiledAccessionLocation in document
1Section 01, Anshul ThakralDEF 14A2026-04-270001193125-26-178733Section “Summary Compensation Table” · page 40. As printed: 11,584,483. Filing ↗machine: t114 · r4 · c39 · span 498934–498944
2Section 01, Thomas PikeDEF 14A2026-04-270001193125-26-178733Section “Summary Compensation Table” · page 40. As printed: 7,791,722. Filing ↗machine: t114 · r17 · c39 · span 537950–537959
3Section 01, Jill McConnellDEF 14A2026-04-270001193125-26-178733Section “Summary Compensation Table” · page 40. As printed: 1,680,873. Filing ↗machine: t114 · r7 · c39 · span 508281–508290
4Section 01, Mark MoraisDEF 14A2026-04-270001193125-26-178733Section “Summary Compensation Table” · page 40. As printed: 1,616,788. Filing ↗machine: t114 · r12 · c39 · span 522968–522977
5Section 01, Peter NeupertDEF 14A2026-04-270001193125-26-178733Section “Summary Compensation Table” · page 40. As printed: 1,145,261. Filing ↗machine: t114 · r23 · c39 · span 553132–553141
6Section 03, Jill McConnell PSUDEF 14A1900-01-010001193125-26-178733Section “Grants of Plan-Based Awards” · grants of plan-based awards table. Filing ↗machine: span 605668–605674
7Section 03, Mark Morais PSUDEF 14A1900-01-010001193125-26-178733Section “Grants of Plan-Based Awards” · grants of plan-based awards table. Filing ↗machine: span 623160–623166
8Section 03, Peter Neupert RSUDEF 14A1900-01-010001193125-26-178733Section “Grants of Plan-Based Awards” · grants of plan-based awards table. Filing ↗machine: span 646422–646429
9Section 03, Thomas Pike RSUDEF 14A1900-01-010001193125-26-178733Section “Grants of Plan-Based Awards” · grants of plan-based awards table. Filing ↗machine: span 640028–640035
10Section 03, Anshul Thakral PSUDEF 14A1900-01-010001193125-26-178733Section “Grants of Plan-Based Awards” · grants of plan-based awards table. Filing ↗machine: span 594478–594487
11Section 03, Jill McConnell PSUDEF 14A1900-01-010001193125-26-178733Section “Grants of Plan-Based Awards” · grants of plan-based awards table. Filing ↗machine: span 609420–609427
12Section 03, Mark Morais PSUDEF 14A1900-01-010001193125-26-178733Section “Grants of Plan-Based Awards” · grants of plan-based awards table. Filing ↗machine: span 625910–625917
13Section 03, Anshul Thakral RSUDEF 14A1900-01-010001193125-26-178733Section “Grants of Plan-Based Awards” · grants of plan-based awards table. Filing ↗machine: span 597355–597364
14Section 03, Jill McConnell RSUDEF 14A1900-01-010001193125-26-178733Section “Grants of Plan-Based Awards” · grants of plan-based awards table. Filing ↗machine: span 613212–613219
15Section 03, Mark Morais RSUDEF 14A1900-01-010001193125-26-178733Section “Grants of Plan-Based Awards” · grants of plan-based awards table. Filing ↗machine: span 628700–628707
16Section 03, Jill McConnell RSUDEF 14A1900-01-010001193125-26-178733Section “Grants of Plan-Based Awards” · grants of plan-based awards table. Filing ↗machine: span 617004–617011
17Section 03, Mark Morais RSUDEF 14A1900-01-010001193125-26-178733Section “Grants of Plan-Based Awards” · grants of plan-based awards table. Filing ↗machine: span 631490–631497
18Section 07, pay ratioDEF 14A2026-04-270001193125-26-178733Section “CEO Pay Ratio”. As printed: 196 : 1. Filing ↗machine: span 792586–792591
19Section 08, Erin L. RussellDEF 14A2026-04-270001193125-26-178733Section “Director Compensation”. As printed: 502,500. Filing ↗machine: t166 · r8 · c14 · span 924912–924919
20Section 08, Dr. Amrit RayDEF 14A2026-04-270001193125-26-178733Section “Director Compensation”. As printed: 340,000. Filing ↗machine: t166 · r6 · c14 · span 923472–923479
21Section 08, David SmithDEF 14A2026-04-270001193125-26-178733Section “Director Compensation”. As printed: 317,466. Filing ↗machine: t166 · r14 · c14 · span 929319–929326
22Section 08, Machelle SandersDEF 14A2026-04-270001193125-26-178733Section “Director Compensation”. As printed: 310,000. Filing ↗machine: t166 · r10 · c14 · span 926404–926411
23Section 08, Edward PesickaDEF 14A2026-04-270001193125-26-178733Section “Director Compensation”. As printed: 300,000. Filing ↗machine: t166 · r4 · c14 · span 922034–922041
24Section 08, R. Andrew EckertDEF 14A2026-04-270001193125-26-178733Section “Director Compensation”. As printed: 75,000. Filing ↗machine: t166 · r16 · c4 · span 930125–930131
25Section 08, William SharbaughDEF 14A2026-04-270001193125-26-178733Section “Director Compensation”. As printed: 22,500. Filing ↗machine: t166 · r12 · c4 · span 927155–927161
26Section 08, Thomas PikeDEF 14A2026-04-270001193125-26-178733Section “Director Compensation”. As printed: 0. Filing ↗
27Section 08, Anshul ThakralDEF 14A2026-04-270001193125-26-178733Section “Director Compensation”. As printed: 0. Filing ↗
28Section 08, Peter M. NeupertDEF 14A2026-04-270001193125-26-178733Section “Director Compensation”. As printed: 0. Filing ↗
29Section 02, Peter M. Neupert 2026-05-14Form 42026-05-180001965040-26-000057Insider equity transaction reported since the proxy statement. Filing ↗
30Section 02, Peter M. Neupert 2026-05-14Form 42026-05-180001965040-26-000057Insider equity transaction reported since the proxy statement. Filing ↗
31Section 02, Robert Parks 2026-05-18Form 42026-05-200001965040-26-000062Insider equity transaction reported since the proxy statement. Filing ↗
32Section 02, Jill McConnell 2026-06-01Form 42026-06-030001965040-26-000068Insider equity transaction reported since the proxy statement. Filing ↗
33Section 02, Jill McConnell 2026-06-01Form 42026-06-030001965040-26-000068Insider equity transaction reported since the proxy statement. Filing ↗
34Section 02, Mark Morais 2026-06-01Form 42026-06-030001965040-26-000069Insider equity transaction reported since the proxy statement. Filing ↗
35Section 02, Mark Morais 2026-06-01Form 42026-06-030001965040-26-000069Insider equity transaction reported since the proxy statement. Filing ↗
36Section 02, Mark Morais 2026-06-02Form 42026-06-030001965040-26-000069Insider equity transaction reported since the proxy statement. Filing ↗
37Section 02, Jill McConnell 2026-06-02Form 42026-06-030001965040-26-000068Insider equity transaction reported since the proxy statement. Filing ↗
38Section 02, Erin L. Russell 2026-06-10Form 42026-06-120001965040-26-000079Insider equity transaction reported since the proxy statement. Filing ↗
39Section 02, Erin L. Russell 2026-06-10Form 42026-06-120001965040-26-000079Insider equity transaction reported since the proxy statement. Filing ↗
40Section 02, Erin L. Russell 2026-06-10Form 42026-06-120001965040-26-000079Insider equity transaction reported since the proxy statement. Filing ↗
41Section 02, William Sharbaugh 2026-06-10Form 42026-06-120001965040-26-000080Insider equity transaction reported since the proxy statement. Filing ↗
42Section 02, Dr. Amrit Ray 2026-06-10Form 42026-06-120001965040-26-000081Insider equity transaction reported since the proxy statement. Filing ↗
43Section 02, Dr. Amrit Ray 2026-06-10Form 42026-06-120001965040-26-000081Insider equity transaction reported since the proxy statement. Filing ↗
44Section 02, Dr. Amrit Ray 2026-06-10Form 42026-06-120001965040-26-000081Insider equity transaction reported since the proxy statement. Filing ↗
45Section 02, Mark Morais 2026-06-10Form 42026-06-120001965040-26-000082Insider equity transaction reported since the proxy statement. Filing ↗
46Section 02, Peter M. Neupert 2026-06-10Form 42026-06-120001965040-26-000083Insider equity transaction reported since the proxy statement. Filing ↗
47Section 02, Edward Pesicka 2026-06-10Form 42026-06-120001965040-26-000084Insider equity transaction reported since the proxy statement. Filing ↗
48Section 02, Edward Pesicka 2026-06-10Form 42026-06-120001965040-26-000084Insider equity transaction reported since the proxy statement. Filing ↗
49Section 02, Edward Pesicka 2026-06-10Form 42026-06-120001965040-26-000084Insider equity transaction reported since the proxy statement. Filing ↗
50Section 02, David Smith 2026-06-10Form 42026-06-120001965040-26-000085Insider equity transaction reported since the proxy statement. Filing ↗
51Section 02, David Smith 2026-06-10Form 42026-06-120001965040-26-000085Insider equity transaction reported since the proxy statement. Filing ↗
52Section 02, David Smith 2026-06-10Form 42026-06-120001965040-26-000085Insider equity transaction reported since the proxy statement. Filing ↗
53Section 02, David Smith 2026-06-10Form 42026-06-120001965040-26-000085Insider equity transaction reported since the proxy statement. Filing ↗
54Section 02, Machelle Sanders 2026-06-10Form 42026-06-120001965040-26-000086Insider equity transaction reported since the proxy statement. Filing ↗
55Section 02, Machelle Sanders 2026-06-10Form 42026-06-120001965040-26-000086Insider equity transaction reported since the proxy statement. Filing ↗
56Section 02, Machelle Sanders 2026-06-10Form 42026-06-120001965040-26-000086Insider equity transaction reported since the proxy statement. Filing ↗
57Section 02, David Smith 2026-07-20Form 42026-07-270001965040-26-000103Insider equity transaction reported since the proxy statement. Filing ↗
58Section 02, Machelle Sanders 2026-08-03Form 42026-08-050001965040-26-000111Insider equity transaction reported since the proxy statement. Filing ↗
59Section 02, David Smith 2026-08-03Form 42026-08-050001965040-26-000113Insider equity transaction reported since the proxy statement. Filing ↗
60Section 02, Anshul Thakral 2026-08-04Form 42026-08-060001965040-26-000116Insider equity transaction reported since the proxy statement. Filing ↗
61Section 02, Anshul Thakral 2026-08-04Form 42026-08-060001965040-26-000116Insider equity transaction reported since the proxy statement. Filing ↗
62Section 02, Anshul Thakral 2026-08-05Form 42026-08-060001965040-26-000116Insider equity transaction reported since the proxy statement. Filing ↗
63Section 02, Anshul Thakral 2026-08-05Form 42026-08-060001965040-26-000116Insider equity transaction reported since the proxy statement. Filing ↗
64Section 02, Anshul Thakral 2026-08-06Form 42026-08-070001965040-26-000119Insider equity transaction reported since the proxy statement. Filing ↗
65Section 02, Anshul Thakral 2026-08-06Form 42026-08-070001965040-26-000119Insider equity transaction reported since the proxy statement. Filing ↗
66Section 02, Mark Morais 2026-08-18Form 42026-08-190001965040-26-000134Insider equity transaction reported since the proxy statement. Filing ↗
67Section 02, Mark Morais 2026-08-18Form 42026-08-190001965040-26-000134Insider equity transaction reported since the proxy statement. Filing ↗
68Section 02, Mark Morais 2026-08-19Form 42026-08-190001965040-26-000134Insider equity transaction reported since the proxy statement. Filing ↗
69Section 02, Mark Morais 2026-09-08Form 42026-09-100001965040-26-000138Insider equity transaction reported since the proxy statement. Filing ↗
70Section 02, Mark Morais 2026-09-08Form 42026-09-100001965040-26-000138Insider equity transaction reported since the proxy statement. Filing ↗
71Section 02, Erin L. Russell 2026-09-08Form 42026-09-100001965040-26-000140Insider equity transaction reported since the proxy statement. Filing ↗
72Section 02, Erin L. Russell 2026-09-08Form 42026-09-100001965040-26-000140Insider equity transaction reported since the proxy statement. Filing ↗
73Section 02, Erin L. Russell 2026-09-09Form 42026-09-100001965040-26-000140Insider equity transaction reported since the proxy statement. Filing ↗
74Section 02, Mark Morais 2026-09-09Form 42026-09-100001965040-26-000138Insider equity transaction reported since the proxy statement. Filing ↗
75Section 02, Jason Fredrick Knoblauch 2026-09-10Form 42026-09-140001965040-26-000144Insider equity transaction reported since the proxy statement. Filing ↗
76Section 06, 2026 voteForm 8-K2026-06-120001628280-26-042827Item 5.07 · say-on-pay result. As reported: 94.82% (votes for as printed: 73,544,293). Filing ↗
77Section 06, 2025 voteForm 8-K2025-06-120001965040-25-000036Item 5.07 · say-on-pay result. As reported: 95.13% (votes for as printed: 68,050,281). Filing ↗
78Section 06, 2024 voteForm 8-K2024-05-160001965040-24-000024Item 5.07 · say-on-pay result. As reported: 91.67% (votes for as printed: 71,701,466). Filing ↗
79Section 01 trend, Δ column (computed)Computed——Δ = current-FY total − prior-FY total per named officer.machine: formula: Δ = FY(n) − FY(n−1)
80Section 03b vehicle mix (computed)Computed——RSU / PSU / Options grant-date fair values summed per officer from the grants table; % performance-vested = PSU ÷ (RSU+PSU+Options).machine: formula: sums + PSU ratio
81Section 09b board cost (computed)Computed——Cash 607,466 + equity 1,260,000 + all other 0 = 1,867,466, summed across the director compensation table rows.machine: formula: Σ = 1,867,466
82Exelixis, Inc., Section 10b CEO totalDEF 14A2026-04-150000939767-26-000046CEO total compensation as printed in Exelixis, Inc.'s own proxy. As printed: 33,239,183. Filing ↗machine: r2 · c10 · span 2655516–2655526
83Bausch + Lomb Corporation, Section 10b CEO totalDEF 14A2026-04-100001140361-26-014234CEO total compensation as printed in Bausch + Lomb Corporation's own proxy. As printed: 32,194,326. Filing ↗machine: r2 · c27 · span 1103747–1103757
84Jazz Pharmaceuticals plc, Section 10b CEO totalDEF 14A2026-06-080001232524-26-000029CEO total compensation as printed in Jazz Pharmaceuticals plc's own proxy. As printed: 19,151,558. Filing ↗machine: r3 · c27 · span 1437369–1437379
85Organon & Co., Section 10b CEO totalDEF 14A2026-04-240001193125-26-177411CEO total compensation as printed in Organon & Co.'s own proxy. As printed: 15,813,296. Filing ↗machine: r30 · c18 · span 3922588–3922598
86Charles River Laboratories International, Inc., Section 10b CEO totalDEF 14A2026-03-310001104659-26-037367CEO total compensation as printed in Charles River Laboratories International, Inc.'s own proxy. As printed: 15,435,220. Filing ↗machine: r1 · c53 · span 1119658–1119668
87Haemonetics Corporation, Section 10b CEO totalDEF 14A2026-06-090000313143-26-000074CEO total compensation as printed in Haemonetics Corporation's own proxy. As printed: 12,044,701. Filing ↗machine: span 718173–718183
88Fortrea Holdings (subject), Section 10b CEO totalDEF 14A2026-04-270001193125-26-178733CEO total compensation as printed in Fortrea Holdings's own proxy. As printed: 11,584,483. Filing ↗machine: t114 · r4 · c39 · span 498934–498944
89Medpace Holdings, Inc., Section 10b CEO totalDEF 14A2026-04-010001668397-26-000012CEO total compensation as printed in Medpace Holdings, Inc.'s own proxy. As printed: 11,443,766. Filing ↗machine: t43 · r3 · c9 · span 495770–495781
90QuidelOrtho Corporation, Section 10b CEO totalDEF 14A2026-04-270001906324-26-000018CEO total compensation as printed in QuidelOrtho Corporation's own proxy. As printed: 11,255,782. Filing ↗machine: r4 · c24 · span 760612–760622
91Sotera Health Company, Section 10b CEO totalDEF 14A2026-04-080001104659-26-040937CEO total compensation as printed in Sotera Health Company's own proxy. As printed: 10,656,063. Filing ↗machine: span 996859–996869
92Integra LifeSciences, Section 10b CEO totalDEF 14A2026-04-060000917520-26-000015CEO total compensation as printed in Integra LifeSciences's own proxy. As printed: 9,375,551. Filing ↗machine: r2 · c30 · span 880204–880213
93Enovis Corporation, Section 10b CEO totalDEF 14A2026-04-060001493152-26-015302CEO total compensation as printed in Enovis Corporation's own proxy. As printed: 9,242,161. Filing ↗machine: r1 · c37 · span 876874–876883
94Perrigo Company plc, Section 10b CEO totalDEF 14A2026-03-200001585364-26-000024CEO total compensation as printed in Perrigo Company plc's own proxy. As printed: 9,042,603. Filing ↗machine: r3 · c12 · span 2143273–2143282
95DENTSPLY SIRONA Inc., Section 10b CEO totalDEF 14A2026-04-230000818479-26-000125CEO total compensation as printed in DENTSPLY SIRONA Inc.'s own proxy. As printed: 8,760,139. Filing ↗machine: r5 · c27 · span 1201378–1201387
96Bio-Rad Laboratories, Section 10b CEO totalDEF 14A2026-03-250000012208-26-000020CEO total compensation as printed in Bio-Rad Laboratories's own proxy. As printed: 7,995,841. Filing ↗machine: r2 · c24 · span 654200–654209
97Alkermes plc, Section 10b CEO totalDEF 14A2026-04-060001193125-26-143977CEO total compensation as printed in Alkermes plc's own proxy. As printed: 7,915,081. Filing ↗machine: r3 · c33 · span 2508258–2508267
98CONMED Corporation, Section 10b CEO totalDEF 14A2026-04-070000816956-26-000047CEO total compensation as printed in CONMED Corporation's own proxy. As printed: 7,634,873. Filing ↗machine: r3 · c27 · span 1186564–1186573
99Teleflex Incorporated, Section 10b CEO totalDEF 14A2026-04-130000096943-26-000039CEO total compensation as printed in Teleflex Incorporated's own proxy. As printed: 6,732,419. Filing ↗machine: span 558736–558745
100Bruker Corporation, Section 10b CEO totalDEF 14A2026-04-100001193125-26-151305CEO total compensation as printed in Bruker Corporation's own proxy. As printed: 4,706,388. Filing ↗machine: t77 · r2 · c18 · span 987303–987312
101Section 10a, Organon & Co. reciprocityDEF 14A—0001193125-26-177411Organon & Co.'s most recent proxy was read; its disclosed peer group does not include Fortrea Holdings. Filing ↗
102Section 10a, Bausch + Lomb Corporation reciprocityDEF 14A—0001140361-26-014234Bausch + Lomb Corporation's most recent proxy was read; its disclosed peer group does not include Fortrea Holdings. Filing ↗
103Section 10a, Charles River Laboratories International, Inc. reciprocityDEF 14A—0001104659-26-037367Charles River Laboratories International, Inc. names Fortrea Holdings in its own disclosed peer group (read from its most recent proxy). Filing ↗
104Section 10a, Exelixis, Inc. reciprocityDEF 14A—0000939767-26-000046Exelixis, Inc.'s most recent proxy was read; its disclosed peer group does not include Fortrea Holdings. Filing ↗
105Section 10a, Integra LifeSciences reciprocityDEF 14A—0000917520-26-000015Integra LifeSciences's most recent proxy was read; its disclosed peer group does not include Fortrea Holdings. Filing ↗
106Section 10a, Jazz Pharmaceuticals plc reciprocityDEF 14A—0001232524-26-000029Jazz Pharmaceuticals plc's most recent proxy was read; its disclosed peer group does not include Fortrea Holdings. Filing ↗
107Section 10a, DENTSPLY SIRONA Inc. reciprocityDEF 14A—0000818479-26-000125DENTSPLY SIRONA Inc.'s most recent proxy was read; its disclosed peer group does not include Fortrea Holdings. Filing ↗
108Section 10a, Sotera Health Company reciprocityDEF 14A—0001104659-26-040937Sotera Health Company's most recent proxy was read; its disclosed peer group does not include Fortrea Holdings. Filing ↗
109Section 10a, Teleflex Incorporated reciprocityDEF 14A—0000096943-26-000039Teleflex Incorporated's most recent proxy was read; its disclosed peer group does not include Fortrea Holdings. Filing ↗
110Section 10a, Bruker Corporation reciprocityDEF 14A—0001193125-26-151305Bruker Corporation's most recent proxy was read; its disclosed peer group does not include Fortrea Holdings. Filing ↗
111Section 10a, CONMED Corporation reciprocityDEF 14A—0000816956-26-000047CONMED Corporation's most recent proxy was read; its disclosed peer group does not include Fortrea Holdings. Filing ↗
112Section 10a, Haemonetics Corporation reciprocityDEF 14A—0000313143-26-000074Haemonetics Corporation's most recent proxy was read; its disclosed peer group does not include Fortrea Holdings. Filing ↗
113Section 10a, Medpace Holdings, Inc. reciprocityDEF 14A—0001668397-26-000012Medpace Holdings, Inc. names Fortrea Holdings in its own disclosed peer group (read from its most recent proxy). Filing ↗
114Section 10a, Perrigo Company plc reciprocityDEF 14A—0001585364-26-000024Perrigo Company plc's most recent proxy was read; its disclosed peer group does not include Fortrea Holdings. Filing ↗
115Section 10a, QuidelOrtho Corporation reciprocityDEF 14A—0001906324-26-000018QuidelOrtho Corporation names Fortrea Holdings in its own disclosed peer group (read from its most recent proxy). Filing ↗

The Pay Desk — the free weekly executive pay briefing, one company at a time, every number traceable to a public filing.

You'll confirm on The Pay Desk's sign-up page.